Macquarie upgrades Amaysim’s earnings forecasts and target price
Historical share price performances are not an indication of future trading patterns. Consequently, any investment decision should not be founded on commentary, projections and data emanating from broker coverage or share price trends.
However, with the material impact of Vaya, along with other initiatives taken by the company gaining traction in the second half, AYS delivered an impressive full-year result on Friday.
Analysts at Macquarie Wealth Management noted that the underlying fiscal 2016 EBITDA of $35.4 million was in line with management’s guidance which was in a range between $35 million and $36 million.
This represented robust year- It has been an up-and-down 12 months for diversified telco amaysim (ASX: AYS), both operationally and from a share price point of view.
After listing on the ASX in July 2015 AYS’s shares traded in a tight range in the vicinity of $2.20 before the company announced the acquisition of Vaya providing it with a dual brand strategy, a development that has been important in terms of driving a strong performance in the second half of fiscal 2016.
AYS’s share price was hammered in February, falling from more than $3.00 to an all-time low of $1.30 after the company delivered a poor first half result.
Year-on-year growth of $19 million. However, more importantly it restored faith in the business model and this was evident in the share price response as it increased from the previous day’s close of $1.79 to hit an intraday high of $2.20 before closing at $2.09.
From an operational perspective, the headway AYS has made in a short period of time since it listed on the ASX in July 2015 is impressive. The table below indicates acquisitions made during this period as well as strategic initiatives aimed at attracting mobile users to its brand.
Macquarie is of the view that this has laid a strong foundation for future growth, evidence of which was provided in its full-year result and this prompted the broker to upgrade earnings per share forecasts for fiscal 2017 and 2018 by 7.5% and 2.2% respectively.
The broker also substantially increased its share price target from $2.00 to $2.50 while maintaining an outperform recommendation.
The price target implies a 25% premium to Monday’s closing price of $2.00. While some shareholders may have sold into last Friday’s strong rally it should be remembered that AYS is recovering off what could be considered an oversold base.
Based on yesterday’s closing price, AYS is trading on a PE multiple of 12.9 relative to Macquarie’s fiscal 2017 earnings per share forecasts. As can be seen in the table below, AYS is generating strong growth in revenues, earnings and subscriber numbers, perhaps suggesting that its current forward PE multiple does not take into account the company’s growth profile.
It should be noted that broker recommendations can change, and earnings projections and target prices may not be met.
Short-term positions in small, early stage ASX companies,
with high potential and near term price catalysts.
Focusing on resource exploration, early-stage tech, and biotech.
Exceptional opportunities across a broad range of
early-stage growth sectors with strong management.
Seeking 1,000% plus returns across medium to long-term holds.
Longer-term positions in a variety of sectors.
Seeking strong management where traction is established and have entered into a growth phase.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.